International Foundation of Employee Benefit Plans

“GLP-1 drugs accounted for 11.4% of corporate employers’ total annual claims in 2025, up from 6.9% in 2023.”

“Average health-benefit costs per employee rose 6% last year and are projected to climb another 6.7% this year.”